Endovascular Treatment of Peripheral Arterial Disease: Techniques, Outcomes, and Technological Advances

Endovascular therapy has revolutionized the management of peripheral arterial disease (PAD), offering minimally invasive alternatives to traditional open surgical approaches. Over the past three decades, rapid technological advances and evolving techniques have expanded the scope of endovascular interventions, allowing for treatment of increasingly complex arterial lesions with reduced procedural morbidity and mortality. This comprehensive guide explores the spectrum of contemporary endovascular approaches for peripheral arterial disease, including established techniques, emerging technologies, clinical outcomes, and future directions in this dynamic field of vascular medicine.

Evolution of Endovascular Therapy

历史视角

The journey from experimental to mainstream:

• Early developments:
• Dotter’s first angioplasty (1964)
• Grüntzig’s balloon catheter introduction (1974)
• Early stent designs (1980s)
• Limited to focal, proximal disease

• High restenosis and technical failure rates

• Technological milestones:

• Self-expanding stents (1990s)
• Hydrophilic wires and low-profile systems
• Drug-coated technologies (2000s)
• Purpose-designed crossing tools

• Advanced imaging integration

• Paradigm shifts:

• “Endovascular first” approach adoption
• Extension to infrapopliteal vessels
• Treatment of chronic total occlusions
• Multi-level intervention capabilities
• Outpatient and office-based procedures

Contemporary Treatment Paradigms

Current approaches to PAD intervention:

• Treatment strategy evolution:
• Shift from “surgery first” to “endovascular first”
• Tailored approach based on:
  • Anatomical complexity
  • Patient comorbidities
  • Symptom severity
  • Tissue loss characteristics
  • Prior interventions
• Preservation of surgical options

• Hybrid procedures when appropriate

• Guidelines and consensus documents:

• Society for Vascular Surgery guidelines
• European Society for Vascular Surgery recommendations
• TASC II classification (and subsequent updates)
• Inter-Society Consensus for Management of PAD

• Appropriate use criteria development

• Decision-making frameworks:

• Anatomical complexity assessment
• Patient risk stratification
• Symptom severity consideration
• Tissue loss classification (WIfI)
• Functional status evaluation
• Life expectancy considerations

Endovascular Techniques and Technologies

访问策略

Evolving approaches to arterial entry:

• Common femoral access:
• Traditional antegrade or retrograde approach
• Ultrasound guidance standard
• Closure device options
• Complications and management

• 解剖学方面的考虑

• Alternative access sites:

• Radial approach (growing adoption)
• Pedal access for retrograde interventions
• Popliteal access in selected cases
• Brachial/axillary options

• Direct puncture techniques

• Access considerations:

• Vessel diameter and disease
• Procedural complexity
• Equipment compatibility
• Closure options
• Patient factors (obesity, scarring)

Lesion Crossing Strategies

Techniques for navigating occlusions:

• Intraluminal approaches:
• Wire selection principles
• Support catheter techniques
• Escalating strategies
• Antegrade techniques

• 专用交叉导线

• Subintimal techniques:

• 受控解剖
• Re-entry device options
• SAFARI 技术（动脉内膜下牙线与抗逆行介入术）
• Complications and management

• Long-term outcomes considerations

• Retrograde approaches:

• Indications and patient selection
• Access site options
• Wire externalization techniques
• Combined antegrade-retrograde strategies
• Complications and management

Balloon Angioplasty Technologies

Evolution beyond simple dilation:

• Conventional balloon angioplasty:
• 作用机制
• Appropriate sizing principles
• Inflation strategies
• Role in modern algorithm

• Limitations and failure modes

• 特色气球:

• 切割气球
• 给气球计分
• 超高压球囊
• Focal force balloons

• 特定机制的应用

• 涂药气球:

• 作用机制
• Available technologies and drug types
• Evidence base by anatomical location
• 选择患者的注意事项
• Safety considerations and monitoring

Stent Technologies

Expanding options for scaffolding:

• 裸金属支架:
• 自膨胀式与气球膨胀式
• Material considerations (nitinol, stainless steel)
• Design features (cell structure, flexibility)
• Sizing and deployment techniques

• Contemporary role in treatment algorithm

• 药物洗脱支架:

• 作用机制
• Available platforms and drugs
• Evidence base by location
• Restenosis reduction data

• Long-term outcomes

• Covered stents and stent-grafts:

• Design variations
• Material considerations
• Applications (occlusive disease, aneurysm, perforation)
• Specific anatomical considerations

• Thrombosis risk management

• Specialized stent designs:

• Interwoven stents
• Biomimetic designs
• Variable radial force platforms
• Tapered configurations
• Location-specific designs

Atherectomy and Debulking Technologies

Plaque modification approaches:

• 定向粥样硬化切除术:
• 作用机制
• 设备选项
• Appropriate applications
• 技术优化

• 并发症管理

• 旋转动脉粥样硬化切除术:

• Mechanism and device options
• Orbital vs. traditional rotational
• Technique considerations
• Embolization risk management

• Contemporary applications

• 激光粥样斑块切除术:

• Photochemical and photothermal effects
• 技术优化
• In-stent restenosis applications
• Calcium modification capabilities

• Safety considerations

• 综合方法:

• Atherectomy with drug-coated balloons
• Debulking before stenting
• Lesion preparation concepts
• Evidence for combined strategies
• 成本效益方面的考虑

专业技术

应对具体挑战：

• Chronic total occlusion (CTO) devices:
• 专用交叉导线
• Re-entry technologies
• 支撑导管
• Specialized techniques

• Case selection for success

• 栓塞保护:

• Filter devices
• Proximal and distal protection
• Indications and evidence
• 技术考虑因素

• Emerging approaches

• 岩体成形术:

• 作用机制
• Calcium modification capabilities
• 技术考虑因素
• 证据基础
• Role in treatment algorithm

Anatomical Considerations and Approaches

Aortoiliac Interventions

Proximal inflow treatment:

• Lesion classification:
• TASC II categories
• Anatomical patterns
• Calcification assessment
• Involvement of bifurcation

• Associated aneurysmal disease

• Technical approaches:

• Balloon-expandable vs. self-expanding stents
• Kissing stent techniques
• CERAB (Covered Endovascular Reconstruction of Aortic Bifurcation)
• Management of common femoral involvement

• Access considerations

• Outcomes and considerations:

• Excellent long-term patency (80-90% at 5 years)
• Durability approaching surgical options
• Complications (dissection, rupture, embolization)
• 监控协议
• Reintervention strategies

Femoropopliteal Interventions

Addressing the challenging superficial femoral artery:

• Lesion characteristics:
• Length considerations
• Calcification patterns
• Involvement of adductor canal
• Popliteal extension

• Previous intervention impact

• Treatment strategies:

• Drug-coated balloon primary role
• Selective stenting approaches
• Atherectomy for specific morphologies
• Consideration of biomechanical forces

• Management of in-stent restenosis

• Outcomes by modality:

• Plain balloon angioplasty (30-50% primary patency at 1 year)
• Drug-coated balloons (70-80% primary patency at 1 year)
• Bare metal stents (60-70% primary patency at 1 year)
• Drug-eluting stents (70-85% primary patency at 1 year)
• 影响耐用性的因素

Infrapopliteal Interventions

Below-the-knee approaches for critical limb ischemia:

• 解剖学方面的考虑:
• Vessel diameter challenges
• Diffuse disease patterns
• 钙化负担
• Involvement of tibial-peroneal trunk

• Pedal arch status

• Technical approaches:

• Focus on luminal gain vs. patency
• Balloon angioplasty as mainstay
• Emerging role of drug-coated balloons
• Selective stenting (bailout)

• Consideration of angiosome concept

• Outcomes and goals:

• Focus on wound healing and limb salvage
• Technical success rates (>90%)
• Limited long-term patency
• 再干预频率
• Impact on amputation-free survival

临床结果和证据基础

Claudication Outcomes

Results for quality of life improvement:

• Hemodynamic success:
• ABI improvement (typically 0.1-0.3)
• Exercise capacity enhancement
• Symptom resolution rates (60-80%)
• Durability considerations

• Reintervention frequencies

• 功能性成果:

• Walking distance improvement
• Quality of life enhancement
• Return to activities
• Patient satisfaction

• Cost-effectiveness data

• 主要临床试验:

• THUNDER and LEVANT (drug-coated balloons)
• Zilver PTX (drug-eluting stents)
• IMPERIAL (self-expanding drug-eluting stents)
• EXCITE ISR (laser for in-stent restenosis)
• REALITY (lithoplasty)

Critical Limb Ischemia Outcomes

Results for limb salvage:

• 技术成功率:

• 90% for most lesion types

• Challenges with calcified disease
• Impact of outflow status
• Multilevel disease considerations

• Complete revascularization vs. targeted perfusion

• Clinical endpoints:

• Wound healing (60-80% at 1 year)
• Limb salvage (80-90% at 1 year)
• Amputation-free survival (60-70% at 1 year)
• Reintervention rates (30-40% at 1 year)

• 对生活质量的影响

• 主要临床试验:

• BASIL trial (surgical vs. endovascular)
• BEST-CLI (ongoing comparative effectiveness)
• PREVENT III (surgical benchmark)
• PARADISE (pedal access)
• DANCE (drug delivery for CLI)

比较效益

Endovascular vs. surgical approaches:

• Claudication comparisons:
• Similar symptom improvement
• Lower periprocedural complications with endovascular
• Higher reintervention rates with endovascular
• Surgical durability advantage

• Patient preference considerations

• Critical limb ischemia comparisons:

• Similar limb salvage rates
• Lower perioperative morbidity with endovascular
• Higher reintervention rates with endovascular
• Consideration of patient life expectancy

• Impact of comorbidities on approach selection

• Hybrid procedure outcomes:

• Combined open and endovascular approaches
• Common femoral endarterectomy with endovascular outflow
• Sequential interventions
• Tailored approaches for complex anatomy
• Preservation of conduit for future procedures

并发症和处理

手术并发症

Recognition and management approaches:

• 访问网站的复杂性:
• Hematoma (3-5%)
• Pseudoaneurysm (1-3%)
• Arteriovenous fistula (<1%)
• Infection (rare)

• Management strategies

• 与血管有关的并发症:

• Dissection (5-10%)
• Perforation (1-2%)
• Rupture (<1%)
• Acute thrombosis (1-3%)

• Distal embolization (2-5%)

• 全身并发症:

• Contrast nephropathy (5-10%)
• Radiation exposure considerations
• 过敏反应
• 心血管事件
• 预防战略

术后管理

Optimizing outcomes after intervention:

• 药物疗法:
• 抗血小板疗法
• 他汀类药物治疗
• 抗血栓形成的考虑因素
• 风险因素调整

• 双重抗血小板疗法的持续时间

• 监控协议:

• Clinical follow-up schedule
• 无创检测方法
• 双工超声标准
• Role of ABI monitoring

• 干预触发器

• Reintervention strategies:

• Approach to restenosis
• Management of in-stent restenosis
• Consideration of alternative modalities
• Timing optimization
• Preservation of future options

未来方向和新兴技术

Novel Therapeutic Approaches

Innovations on the horizon:

• Bioresorbable technologies:
• Scaffolds and stents
• Drug delivery platforms
• Temporary mechanical support
• Advantages and limitations

• Current evidence and challenges

• 给药创新:

• Sustained release technologies
• Novel antiproliferative agents
• Combination therapies
• 定向输送系统

• Biological agents

• Vessel preparation technologies:

• Advanced atherectomy concepts
• Specialized calcium modification
• Combination devices
• Precision plaque removal
• Reduced embolization approaches

Advanced Imaging Integration

Enhancing procedural precision:

• Intravascular imaging:
• IVUS applications
• OCT emerging role
• Lesion assessment
• Intervention guidance

• Outcome prediction

• Co-registration technologies:

• Fusion imaging
• 3D roadmapping
• Real-time integration
• Radiation reduction strategies

• Enhanced precision

• Artificial intelligence applications:

• Lesion characterization
• Outcome prediction
• Procedural planning
• Complication risk assessment
• Decision support tools

医疗免责声明

重要通知: This information is provided for educational purposes only and does not constitute medical advice. Endovascular treatment of peripheral arterial disease represents a specialized intervention that should only be performed by qualified healthcare professionals with appropriate training and expertise. The techniques and technologies discussed should only be implemented under appropriate medical supervision. Individual treatment decisions should be based on patient-specific factors, current clinical guidelines, and physician judgment. If you have been diagnosed with peripheral arterial disease or are experiencing symptoms such as leg pain with walking, non-healing wounds, or color changes in your feet, please consult with a healthcare professional for proper evaluation and treatment recommendations. This article is not a substitute for professional medical advice, diagnosis, or treatment.

结论

Endovascular therapy for peripheral arterial disease has evolved dramatically over the past three decades, transforming the management landscape for this common circulatory condition. The expanding array of techniques and technologies allows for increasingly personalized approaches to revascularization, with consideration of anatomical complexity, patient risk factors, and clinical presentation. While challenges remain, particularly regarding long-term durability in certain anatomical locations, the continued refinement of devices, techniques, and adjunctive therapies promises to further enhance outcomes. The optimal approach to peripheral arterial disease increasingly involves a thoughtful integration of endovascular and surgical options, with consideration of patient-specific factors and goals of care. As technology continues to advance and evidence accumulates, the endovascular treatment of peripheral arterial disease will likely continue its evolution toward more effective, durable, and patient-centered interventions.